GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortrea Holdings Inc (NAS:FTRE) » Definitions » Price-to-Operating-Cash-Flow

Fortrea Holdings (Fortrea Holdings) Price-to-Operating-Cash-Flow : 17.52 (As of May. 12, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Fortrea Holdings Price-to-Operating-Cash-Flow?

As of today (2024-05-12), Fortrea Holdings's share price is $33.03. Fortrea Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.89. Hence, Fortrea Holdings's Price-to-Operating-Cash-Flow Ratio for today is 17.52.

The historical rank and industry rank for Fortrea Holdings's Price-to-Operating-Cash-Flow or its related term are showing as below:

FTRE' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.78   Med: 15.96   Max: 21.29
Current: 17.52

During the past 4 years, Fortrea Holdings's highest Price-to-Operating-Cash-Flow Ratio was 21.29. The lowest was 8.78. And the median was 15.96.

FTRE's Price-to-Operating-Cash-Flow is ranked better than
65.32% of 297 companies
in the Biotechnology industry
Industry Median: 26.92 vs FTRE: 17.52

Fortrea Holdings's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $0.14. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.89.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Fortrea Holdings was 90.40% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -6.00% per year.

During the past 4 years, Fortrea Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was -6.00% per year. The lowest was -6.00% per year. And the median was -6.00% per year.


Fortrea Holdings Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Fortrea Holdings's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fortrea Holdings Price-to-Operating-Cash-Flow Chart

Fortrea Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
- - - 18.51

Fortrea Holdings Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 11.45 13.85 18.51

Competitive Comparison of Fortrea Holdings's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Fortrea Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fortrea Holdings's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fortrea Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Fortrea Holdings's Price-to-Operating-Cash-Flow falls into.



Fortrea Holdings Price-to-Operating-Cash-Flow Calculation

Fortrea Holdings's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=33.03/1.885
=17.52

Fortrea Holdings's Share Price of today is $33.03.
Fortrea Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.89.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Fortrea Holdings Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Fortrea Holdings's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Fortrea Holdings (Fortrea Holdings) Business Description

Traded in Other Exchanges
Address
8 Moore Drive, Durham, NC, USA, 27709
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after LabCorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
Executives
Thomas Pike officer: Chief Executive Officer C/O ACCENTURE, 161 N. CLARK STREET, 23RD FLOOR, CHICAGO IL 60601
Peter M Neupert director 13920 SE EASTGATE WAY, STE 300, BELLEVUE WA 98005
Betty D Larson director GE HEALTHCARE TECHNOLOGIES INC., 500 W. MONROE, CHICAGO IL 60661
R Andrew Eckert director THREE RAVINIA DRIVE, ATLANTA GA 30346
Edward A Pesicka director 9120 LOCKWOOD BLVD, MECHANICSVILLE VA 23116
Amrit Ray director 60 LEVERONI COURT, NOVATO CA 94949
Amanda M. Warren officer: Chief Accounting Officer 8 MOORE DRIVE, DURHAM NC 27703
David Ross Smith director 251 BALLARDVALE STREET, WILMINGTON MA 01887
Van Der Vaart Sandra D director, officer: President and Secretary 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Glenn A Eisenberg director, officer: Executive Vice President P O BOX 1017, CHARLOTTE NC 28201-1017
James S. Hanson officer: General Counsel 79 TW ALEXANDER DRIVE, 4501 RESEARCH COMMONS, SUITE 100, RESEARCH TRIANGLE PARK NC 27709
Laboratory Corp Of America Holdings 10 percent owner 358 S MAIN ST, BURLINGTON NC 27215
Jill G. Mcconnell officer: Chief Financial Officer 8 MOORE DRIVE, DURHAM NC 27703
Mark A. Morais officer: Chief Operating Officer 8 MOORE DRIVE, DURHAM NC 27703
Robert S. Pringle officer: Treasurer 531 SOUTH SPRING STREET, BURLINGTON NC 27215